Suspicion of Hypoglycemic Effect of mRNA Based Covid-19 Vaccines (Polyethylene Glycol) Will Happen , Observational Study on Diabetic Patients at Saudia Arabia
NCT05087225 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2021-11-08
Summary
vaccines for covid-19 are gold strategy and great achievement at this century for protection against complications of covid-19 , development of many vaccines with different technology represent a big challenge for this disease so the world live bad days and the vaccines save world to see the light once again , mRNA based vaccines have a new technology which designed before for cancer therapy, this technology is very effective , producible and fast for future disease targets but these vaccine must contain excipients for preservation of this technology mRNA so we now study these side effects of excipients and we suspect that polyethylene glycol as excipients have big role at hypoglycemic effects with antidiabetic medications like metformin and insulin especially at children and older age
Conditions
- Diabetic Complication
- Covid19 Virus Infection
- Hypoglycemia
- Polyethylene Glycol Adverse Reaction
Interventions
- BIOLOGICAL
-
polyethelyene glycol
the excipients at covid-19 vaccines
Sponsors & Collaborators
-
Ministry of Health, Saudi Arabia
lead OTHER_GOV
Eligibility
- Min Age
- 12 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-11-11
- Primary Completion
- 2022-03-11
- Completion
- 2022-04-01
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
A Study of the Efficacy and Safety of Supaglutide in Healthy Participants
NCT03745885 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease
NCT00479986 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus
NCT00882726 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus
NCT02683746 ·Status: COMPLETED ·Phase: PHASE3
-
SGLT2 Inhibitors and Effects on Hematopoiesis, Inflammation and Metabolic Markers
NCT05408936 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus
NCT00850096 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012)
NCT00972322 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes
NCT01396187 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Response to Glucagon During Hypoglycemia
NCT00817271 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus
NCT05029115 ·Status: ENROLLING_BY_INVITATION
-
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
NCT02973321 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
NCT04591626 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.
NCT05376930 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes Mellitus
NCT04552470 ·Status: COMPLETED ·Phase: PHASE1
-
Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)
NCT02974504 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating PPM-204 In Subjects With Type 2 Diabetes
NCT00425919 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin
NCT02946541 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Supaglutide in Chinese Type 2 Diabetes Patients
NCT04314622 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide
NCT00964262 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
NCT05158244 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Dapagliflozin on Glycemic Variability
NCT02459353 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects
NCT04504370 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy
NCT02926937 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus
NCT04654390 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
NCT04504396 ·Status: COMPLETED ·Phase: PHASE3